Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 824 results for "merck co"

Bionomics says Merck & Co to buy stake for $9 million; extend partnership on pain medication
Pharma Letter

Bionomics says Merck & Co to buy stake for $9 million; extend ...

Australia's Bionomics Limited (ASX: BNO) said US pharma giant Merck & Co (NYSE: MRK) will buy about 21.7 million shares in the company for a total of $9 million and extended the partnership to develop new pain medication. Bionomics chief ... Pharma Letter, 20 hours ago
Nasal Allergy Spray Currently Unavailable Monthly Prescribing Reference, 3 days ago
Jutia Group

Market Update (NYSE:MRK): Dynavax Initiates Immuno-Oncology Clinical Trial Evaluating SD-101 in Combination With Merck's Anti-PD-1 Therapy, KEYTRUDA(R) (pembrolizumab)

[Marketwired] Dynavax Technologies Corporation today announced that it has initiated patient dosing in the company's trial evaluating the combination of two immunotherapies: Dynavax's SD-101 and Merck's KEYTRUDA® . … Read more on this. ...
 Jutia Group16 hours ago Merck To Hold Third-Quarter 2015 Sales And Earnings Conference Call On October 27  TheStreet.com1 week ago Market Update (NYSE:MRK): Merck to Participate at the Morgan Stanley Global Healthcare Conference  Jutia Group3 weeks ago Merck Publishes 2014 Global Corporate Responsibility Report  SPi World News4 weeks ago

Quest Diagnostics Introduces Dako's PD-L1 Companion Diagnostic For KEYTRUDA, Merck & Co.'s Anti-PD-1 Therapy For Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 With Disease Progression On Or After Platinum-Containing Chemotherapy

MADISON, N.J. , Oct. 2, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will provide clinical laboratory testing using the PD-L1 IHC 22C3 PharmDx ...
 BioSpace3 days ago Merck And Pfizer Collaborate With Dako, An Agilent Technologies Company, On Development Of Companion Diagnostic For Investigational Anti-PD-L1 Antibody, Avelumab  TheStreet.com2 weeks ago Merck and Pfizer partner with Dako to develop companion diagnostic test for avelumab  Medical Devices Business Review2 weeks ago Dako gets US FDA approval for new companion diagnostic for lung cancer  Pharma Letter3 days ago

Sigma-Aldrich And Merck KGaA, Darmstadt, Germany, Making Progress Toward Completion Of Planned Acquisition

ST. LOUIS , Sept. 28, 2015 /PRNewswire/ --Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it is making progress toward closing the planned acquisition of the Company by Merck KGaA, Darmstadt, Germany.The closing is now expected within the ...
 TheStreet.com1 week ago
Motley Fool

Here's How Merck Plans to Protect Billions of Dollars in Sales

Source: Merck & Co. It's been a busy month for diabetes trial data; especially data that could have a big impact on Merck & Co. 's ( NYSE:MRK ) top-selling type 2 diabetes drug Januvia. Specifically, Merck released data showing that its ...
 Motley Fool2 weeks ago

EpiPen draws new health line

IN A 2007 purchase of medicines from Merck, pharmaceuticals company Mylan picked up a decades-old product, the EpiPen auto injector for food allergy and bee-sting emergencies. Management first thought to divest the ageing device, which logged only ...
 BDlive3 days ago How Marketing Turned the EpiPen Into a Billion-Dollar Business  Bloomberg2 weeks ago
Motley Fool

Eli Lilly Officially Puts Merck on Notice

Source: National Cancer Institute. Cancer and hepatitis C research may have received the bulk of investors' attention in recent years, but whether you realize it or not, we've witnessed quite an improvement in treatments for type 2 diabetes. ...
 Motley Fool2 weeks ago
Kenya Broadcasting Corporation

Merck, UNESCO, Cambridge Uni unite to accelerate Health Innovations in Africa

. By Christine Muchira Kenyan scientists have scooped 20 of the 100 scholarships to attend the prestigious annual global UNESCO-Merck Africa Research Summit (MARS) in Switzerland. The researchers drawn from African Population Health ...
 Kenya Broadcasting Corporation2 weeks ago

Receive case studies from Merck Serono, Teva, MHRA, Cinfa Biotech GmbH, Selecta Biosciences, Norwegian Medicines Agency and more | Biosimilars and Biobetters

London (PRWEB UK) 27 August 2015 SMi's 6th annual Biosimilars and Biobetters conference will provide the ideal platform to engage in scientific discussions and debate the best practices and solutions to improve industry performance through ...
 PRWeb1 month ago

Innovation will ultimately triumph in this country: Kevin Ali, Merck & Co

Extreme volatility in emerging markets has made life difficult in the past two years, says Merck & Co's emerging markets head Kevin Ali. Despite these challenges, India remains one of the key growth markets for the US company, Ali tells Vikas Dandekar and ...
 Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less